Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016
Standard
Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016. / Lörincz, B B; Simon, C; Möckelmann, N; Knecht, R.
In: HNO, Vol. 64, No. 10, 10.2016, p. 736-40.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016
AU - Lörincz, B B
AU - Simon, C
AU - Möckelmann, N
AU - Knecht, R
PY - 2016/10
Y1 - 2016/10
N2 - The annual meeting of the American Society of Clinical Oncology (ASCO) took place at the beginning of June 2016 in Chicago. This year a total of 28 studies on the treatment of patients with thyroid cancer were presented, described in this review article according to the degree of cancer cell differentiation. The leading curative treatment modality is still surgery. In contrast, kinase inhibitors are being used increasingly within palliative concepts. The latest state of the art of thyroid cancer treatment, both surgical and medical, is summarized in this review.
AB - The annual meeting of the American Society of Clinical Oncology (ASCO) took place at the beginning of June 2016 in Chicago. This year a total of 28 studies on the treatment of patients with thyroid cancer were presented, described in this review article according to the degree of cancer cell differentiation. The leading curative treatment modality is still surgery. In contrast, kinase inhibitors are being used increasingly within palliative concepts. The latest state of the art of thyroid cancer treatment, both surgical and medical, is summarized in this review.
KW - English Abstract
KW - Journal Article
U2 - 10.1007/s00106-016-0246-3
DO - 10.1007/s00106-016-0246-3
M3 - SCORING: Zeitschriftenaufsatz
C2 - 27624902
VL - 64
SP - 736
EP - 740
JO - HNO
JF - HNO
SN - 0017-6192
IS - 10
ER -